Singapore Shares End Marginally Lower; Amplefield Surges 15%
Pharmesis International's Subsidiary to Complete Acquisition of Sichuan Longlife Pharmaceutical
Pharmesis Intl: Financial Statements and Related Announcement-Half Yearly Results
Pharmesis International Flags Net Loss for H1
Pharmesis Intl: Financial Statements and Related Announcement-Profit Guidance
Singapore Shares Down Tracking Global Market Losses; Soilbuild Soars 147%
Pharmesis International Completes Subscription Deal Following Share Issue; Shares Surge 32%
Pharmesis International Secures Approval for Listing of Over 4 Million Shares
Pharmesis International Enters Subscription Agreement for 4.1 Million Additional Shares
Pharmesis to Issue 4 Million New Shares Under Placement
Pharmesis' Attributable Loss for 2023 Widens
Pharmesis Launches New Product Line
Express News | Pharmesis International Flags Losses for H1
Pharmesis International Issues 4.6 Million Shares to Two Subscribers
Pharmesis International Gets Regulatory Nod to List 4.6 Million Shares
Pharmesis International to Issue 4.6 Million Shares to Two Subscribers
Pharmesis International Expects Loss in H2, FY22
Pharmesis International to Post Losses in H1 Amid Lower Sales
Pharmesis International to Swing Back to Profit in FY21
Stocks That Hit 52-Week Highs On Thursday
No Data
No Data